Company / Financials
Beta Bionics, Inc. Financials
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$100.3M
FY2025 · +53.9% YoY
Net Income
-$73.2M
FY2025 · -33.7% YoY
Profit Margin
-73.0%
FY2025 · net income / revenue
ROE
-25.4%
FY2025 · return on equity
Total Assets
$328.7M
FY2025
Total Debt
-
FY2025
Equity
$287.6M
FY2025
ROA
-22.3%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$100.3M+53.9% YoYNet Income HistoryProfit after all expenses and taxes-$73.2M-33.7% YoYGross Profit HistoryRevenue minus cost of goods sold$55.5M+54.8% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$44.7M+52.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$71.7M-58.4% YoYSG&A Expense HistorySelling, general, and administrative expenses$31.0M+73.6% YoYR&D Expense HistoryResearch and development spending$34.8M+32.9% YoYIncome Tax HistoryTotal income tax expense$0EPS (Basic) HistoryBasic earnings per share-$8.60-3.5% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$8.60-3.5% YoY